Cite
MLA Citation
M Weller et al.. “P11.65.B GBM AGILE: A global, phase 2/3 adaptive platform trial to evaluate multiple treatment regimens in newly diagnosed and recurrent glioblastoma.” Neuro-oncology, vol. 24, n.d., p. ii73. http://access.bl.uk/ark:/81055/vdc_100163513168.0x000027